Thank you to everyone that attended the latest installment of the 2020 PAA Webinar Series, Gut Microbiome and Parkinson’s Disease, presented by Dr. Haydeh Payami, PhD and sponsored by Acadia Pharmaceuticals and Amneal Pharmaceuticals.
PD often involves gastrointestinal problems, such as constipation, which may precede motor symptoms by several years. One of the current thoughts is that PD may start in the gut and then spread to the brain. Gut health is, therefore, a focal point in research on the origin of PD as well as its progression and treatment. Critical to gut health is the gut microbiome, that is, the bacteria and other microorganisms that live in the human gut in a symbiotic relationship with their human host. A balanced gut microbiome is essential to keeping us healthy – they help with digestion, keep the lining of the gut intact and pathogens out, help with proper development and functioning of the immune system and even the nervous system. Imbalances in the gut microbiome can interfere with the checks and balances and cause problems for its human host. In this webinar, Dr. Payami will review the current knowledge on the connection between the gut microbiome and PD.
Acadia is an industry leader in the development of therapies for central nervous system disorders. Amneal is a generics and specialty pharmaceuticals company. We are thrilled to have their sponsorship support for this webinar!